Cargando…

SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients

Detalles Bibliográficos
Autores principales: Cheng, Chung-Yi, Hsiao, Shih-Hsin, Fang, Te-Chao, Lin, Yen-Chung, Wang, Jude Chu-Chun, Hung, Ching-Sheng, Chen, Tso-Hsiao, Sue, Yuh-Mou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988583/
https://www.ncbi.nlm.nih.gov/pubmed/35398405
http://dx.doi.org/10.1016/j.jinf.2022.04.011
_version_ 1784682993793630208
author Cheng, Chung-Yi
Hsiao, Shih-Hsin
Fang, Te-Chao
Lin, Yen-Chung
Wang, Jude Chu-Chun
Hung, Ching-Sheng
Chen, Tso-Hsiao
Sue, Yuh-Mou
author_facet Cheng, Chung-Yi
Hsiao, Shih-Hsin
Fang, Te-Chao
Lin, Yen-Chung
Wang, Jude Chu-Chun
Hung, Ching-Sheng
Chen, Tso-Hsiao
Sue, Yuh-Mou
author_sort Cheng, Chung-Yi
collection PubMed
description
format Online
Article
Text
id pubmed-8988583
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89885832022-04-11 SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients Cheng, Chung-Yi Hsiao, Shih-Hsin Fang, Te-Chao Lin, Yen-Chung Wang, Jude Chu-Chun Hung, Ching-Sheng Chen, Tso-Hsiao Sue, Yuh-Mou J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-06 2022-04-07 /pmc/articles/PMC8988583/ /pubmed/35398405 http://dx.doi.org/10.1016/j.jinf.2022.04.011 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Cheng, Chung-Yi
Hsiao, Shih-Hsin
Fang, Te-Chao
Lin, Yen-Chung
Wang, Jude Chu-Chun
Hung, Ching-Sheng
Chen, Tso-Hsiao
Sue, Yuh-Mou
SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients
title SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients
title_full SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients
title_fullStr SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients
title_full_unstemmed SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients
title_short SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients
title_sort sars-cov2 antibody response after a third dose of heterologous chadox1 ncov-19 and moderna vaccine in chronic dialysis patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988583/
https://www.ncbi.nlm.nih.gov/pubmed/35398405
http://dx.doi.org/10.1016/j.jinf.2022.04.011
work_keys_str_mv AT chengchungyi sarscov2antibodyresponseafterathirddoseofheterologouschadox1ncov19andmodernavaccineinchronicdialysispatients
AT hsiaoshihhsin sarscov2antibodyresponseafterathirddoseofheterologouschadox1ncov19andmodernavaccineinchronicdialysispatients
AT fangtechao sarscov2antibodyresponseafterathirddoseofheterologouschadox1ncov19andmodernavaccineinchronicdialysispatients
AT linyenchung sarscov2antibodyresponseafterathirddoseofheterologouschadox1ncov19andmodernavaccineinchronicdialysispatients
AT wangjudechuchun sarscov2antibodyresponseafterathirddoseofheterologouschadox1ncov19andmodernavaccineinchronicdialysispatients
AT hungchingsheng sarscov2antibodyresponseafterathirddoseofheterologouschadox1ncov19andmodernavaccineinchronicdialysispatients
AT chentsohsiao sarscov2antibodyresponseafterathirddoseofheterologouschadox1ncov19andmodernavaccineinchronicdialysispatients
AT sueyuhmou sarscov2antibodyresponseafterathirddoseofheterologouschadox1ncov19andmodernavaccineinchronicdialysispatients